Viveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call Transcript November 10, 2022
Viveve Medical, Inc. beats earnings expectations. Reported EPS is $-0.59, expectations were $-0.66.
Operator: Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call. Please note that this event is recorded. I’ll turn the call over to Ms. Jeannie Swindle, Viveve Senior Director of Corporate Communications. Please go ahead.
Jeannie Swindle: Thank you,...
